PAA 3.03% 17.0¢ pharmaust limited

Ann: Investor Briefings & Webinar Notice, page-72

  1. 2,653 Posts.
    lightbulb Created with Sketch. 1456
    Good to have a clearer picture on trial timeline and what to expect along the path. I am not sure we will get much SP appreciation from here though as broadly speaking it will be now viewed as a 12-18 month waiting period with not much in the middle (accounting for model testing for other conditions). Outside of a buyout before phase 2 results (imo possible but unlikely), investors may not want to tie up capital now when they can do it in 12 months time, closer to readout.

    Not that it matters in the long run.

    I think most who believe are largely locked and loaded and now the 'final' wait begins.

    Let's hope all of the OLE participants remain alive well beyond expectations and MPL continues to help them experience QOL above and beyond SOC.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.0¢ 18.0¢ 16.8¢ $151.1K 877.6K

Buyers (Bids)

No. Vol. Price($)
4 54714 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 371375 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.